Search

everythinglearnresearchcommunity

for

Search:↓

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

Stopping erlotinib improved severe hair loss and skin issues in a patient.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

Rubbing vitamin D3 on skin can help prevent hair loss from chemotherapy and slow breast tumor growth in mice.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Boosting certain cell signals can prevent hair loss from chemotherapy and radiation.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

Deucravacitinib helped a man regrow hair and improve psoriasis.

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Oral tacrolimus helped a rheumatoid arthritis patient regrow hair lost due to alopecia areata.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

The conclusion is that a certain test might help find cancer spread in lymph nodes for melanoma patients, but more research is needed due to false positives.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.